재택 검사 및 홈 헬스케어 시장 : 제품, 구성요소, 서비스 유형, 용도별 - 세계 예측(2025-2030년)

The Home Testing & Home Healthcare Market was valued at USD 273.29 billion in 2023, expected to reach USD 294.96 billion in 2024, and is projected to grow at a CAGR of 8.41%, to USD 481.07 billion by 2030.

The home testing and home healthcare market have emerged as vital components in modern healthcare, aiming to bring medical testing and care into the patient's home environment. This shift is primarily driven by the increasing aging population, rising chronic disease prevalence, and the need for cost-effective healthcare solutions. Home testing includes a wide range of diagnostic kits for blood sugar, cholesterol, pregnancy, and infectious diseases, while home healthcare encompasses services like home nursing, rehabilitation therapies, and medical supplies. The necessity of these solutions is underscored by their ability to reduce hospital visits, ease patient convenience, improve adherence to treatment plans, and allow early detection of diseases. Adaptations of telehealth and IoT devices facilitate seamless integration, data tracking, and remote patient monitoring. Market growth is heavily influenced by technological advancements, increasing consumer awareness, and regulatory approvals of home-use diagnostic devices. Opportunities lie in expanding telemedicine, personalized medicine, and advancing AI-driven diagnostics. To capitalize on these opportunities, companies should invest in developing user-friendly kits, services tailored for chronic disease management, and explore partnerships with technology firms. Despite its promise, the market faces limitations such as regulatory challenges, accuracy concerns of home-use diagnostics, and data privacy issues, which may curb growth. Furthermore, the integration of digital healthcare platforms and wearables presents opportunities for innovation, promising enhanced patient engagement and data analytics capabilities. Companies can focus on developing platforms that ensure data security and integrate with existing healthcare IT systems for a holistic approach. The market is dynamic and competitive, requiring entities to prioritize R&D investments and agile strategies responsive to evolving healthcare needs. Overall, continued advancements in technology, along with strategic partnerships and a focus on consumer-centric solutions, will be key drivers of growth in home-based healthcare solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Home Testing & Home Healthcare Market

The Home Testing & Home Healthcare Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising availability and accessibility of home services
  • Growing prevalence of chronic conditions in adult population
  • Government initiatives to promote home healthcare services
• Market Restraints
  • Lack of precision and risks of product recalls
  • Limitation associated with reimbursement policies
• Market Opportunities
  • Advancement in technologies new home testing equipment
  • Shift in focus on telehealth and emergence of new markets
• Market Challenges
  • Lack of awareness and reluctance of testing in rural areas

Porter's Five Forces: A Strategic Tool for Navigating the Home Testing & Home Healthcare Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Home Testing & Home Healthcare Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Home Testing & Home Healthcare Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Home Testing & Home Healthcare Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Home Testing & Home Healthcare Market

A detailed market share analysis in the Home Testing & Home Healthcare Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Home Testing & Home Healthcare Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Home Testing & Home Healthcare Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Home Testing & Home Healthcare Market

A strategic analysis of the Home Testing & Home Healthcare Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Home Testing & Home Healthcare Market, highlighting leading vendors and their innovative profiles. These include BAYADA Home Health Care, Care UK Group, ConvaTec Group PLC, Drive DeVilbiss International, F. Hoffmann-La Roche Ltd., Hamilton Health Care System, Invacare Corporation, Koninklijke Philips N.V., LHC Group, Inc., Linde PLC, Lowenstein Medical SE & Co. KG, McKesson Corporation, Medline Industries, LP, OMRON Healthcare, Inc., and Vitalograph Ltd..

Market Segmentation & Coverage

This research report categorizes the Home Testing & Home Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Home Healthcare Mobility Care Products, Screening & Monitoring Products, Testing, and Therapeutic Product.
• Based on Component, market is studied across Equipment and Services.
• Based on Services Type, market is studied across Hospice, Infusion Therapy Services, Palliative Care Services, Pregnancy Care Services, Rehabilitation Therapy Services, Respiratory Therapy Services, Skilled Nursing Care Services, and Unskilled Care Services.
• Based on Application, market is studied across Blood Glucose Testing, Cancer Testing, Drug of Abuse Testing, Pregnancy & Fertility Testing, and STD/ STI Testing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising availability and accessibility of home services
    • 5.1.1.2. Growing prevalence of chronic conditions in adult population
    • 5.1.1.3. Government initiatives to promote home healthcare services
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of precision and risks of product recalls
    • 5.1.2.2. Limitation associated with reimbursement policies
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in technologies new home testing equipment
    • 5.1.3.2. Shift in focus on telehealth and emergence of new markets
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and reluctance of testing in rural areas
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Home Testing & Home Healthcare Market, by Product

• 6.1. Introduction
• 6.2. Home Healthcare Mobility Care Products
• 6.3. Screening & Monitoring Products
• 6.4. Testing
• 6.5. Therapeutic Product

7. Home Testing & Home Healthcare Market, by Component

• 7.1. Introduction
• 7.2. Equipment
• 7.3. Services

8. Home Testing & Home Healthcare Market, by Services Type

• 8.1. Introduction
• 8.2. Hospice
• 8.3. Infusion Therapy Services
• 8.4. Palliative Care Services
• 8.5. Pregnancy Care Services
• 8.6. Rehabilitation Therapy Services
• 8.7. Respiratory Therapy Services
• 8.8. Skilled Nursing Care Services
• 8.9. Unskilled Care Services

9. Home Testing & Home Healthcare Market, by Application

• 9.1. Introduction
• 9.2. Blood Glucose Testing
• 9.3. Cancer Testing
• 9.4. Drug of Abuse Testing
• 9.5. Pregnancy & Fertility Testing
• 9.6. STD/ STI Testing

10. Americas Home Testing & Home Healthcare Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Home Testing & Home Healthcare Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Home Testing & Home Healthcare Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BAYADA Home Health Care
• 2. Care UK Group
• 3. ConvaTec Group PLC
• 4. Drive DeVilbiss International
• 5. F. Hoffmann-La Roche Ltd.
• 6. Hamilton Health Care System
• 7. Invacare Corporation
• 8. Koninklijke Philips N.V.
• 9. LHC Group, Inc.
• 10. Linde PLC
• 11. Lowenstein Medical SE & Co. KG
• 12. McKesson Corporation
• 13. Medline Industries, LP
• 14. OMRON Healthcare, Inc.
• 15. Vitalograph Ltd.